• KYODO

  • SHARE

A biotechnology startup in Fukuoka Prefecture is partnering with local authorities to develop a drug to treat COVID-19 using its RNA technology.

Bonac Corp., based in Kurume, says only two other companies in the world are trying to develop a nucleic acid medicine for the respiratory disease caused by the novel coronavirus.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)